PatternsRadar
Sign in

SIGACHISigachi Industries Limited

NSE
Full chart
29.89INR+1.17 (+4.07%)Close · 6 Oct 2026
13 Aug 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹1,142 CrMarket cap
43.4P/E (TTM)
27.3%Delivery

Filings & corporate actions

18 results filed
CSV
Next results · Q2 FY27
Expected 24 Oct 2026 – 14 Nov 2026
Estimate: filed 24–45 days after quarter end, last 4 times
Dividend
₹0.10 per share · last 22 Sept 2026
2026
  • 22 SeptdividendDividend · ₹0.10 per share-1.6%
  • 13 AugresultsResults · Q1 FY27 · consolidated and standalone-1.8%NSE
  • 18 JulshareholdingShareholding · 30 Jun 2026+2.0%NSE
  • 30 MayresultsResults · Q4 FY26 · consolidated and standalone+4.9%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026-3.4%NSE
  • 14 FebresultsResults · Q3 FY26 · consolidated and standalone-3.0%NSE
  • 18 JanshareholdingShareholding · 31 Dec 2025-3.9%NSE

Reaction to results · all yearsrose on day 0 in 7 of 18 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2713 Aug 2026-1.8%+8.2%+36.6%1.3×
Q4 FY2630 May 2026+4.9%-0.9%+11.9%3.3×
Q3 FY2614 Feb 2026-3.0%-8.0%-19.3%0.4×
Q2 FY2624 Oct 2025-2.5%-5.4%-12.7%0.7×
Q1 FY2625 Jul 2025-0.8%-6.4%-20.6%0.8×
Q4 FY2530 May 2025+1.5%+7.7%-7.7%4.4×
Q3 FY2518 Jan 2025+1.6%-11.7%-30.4%3.4×
Q2 FY2513 Nov 2024-2.3%-5.3%+3.0%1.0×
Q1 FY256 Aug 2024-1.5%-6.6%-7.9%0.9×
Q4 FY2427 May 2024-2.4%-11.0%-10.4%1.6×
Q3 FY2420 Jan 2024+10.4%+7.7%+9.1%2.2×
Q2 FY2414 Nov 2023+6.4%+8.4%+2.5%3.3×
Q1 FY2410 Aug 2023-0.9%+6.1%+4.2%1.5×
Q4 FY2325 May 2023-5.0%-3.6%+6.6%1.7×
Q3 FY2330 Jan 2023-1.3%-11.6%-19.0%0.7×
Q2 FY2328 Oct 2022+1.1%-1.7%+0.7%2.9×
Q4 FY2214 May 2022+5.6%0.0%-3.2%4.8×
Q3 FY224 Feb 2022-3.1%-10.9%-26.2%0.4×
Average+0.4%-2.5%-4.6%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY-5.4%
Profit YoY—
Interest cost YoY—
Revenue QoQ-0.5%
Profit QoQ+6.5%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open28.73
Day range28.65 – 31.19
52-week range16.65 – 40.85
From 52w high-26.8%
RSI (14)48.0
ATR (14)1.88
Volume54.10L
Avg volume (20D)61.47L
Rel volume0.88×
Volatility (1Y)53.7%
Turnover₹16.2Cr
SMA 50 / 20029.85 / 24.85

Delivery percentage

Latest · 6 Oct 202627.3%
20-day avg37.6%
1-year avg56.1%
Percentile (own history)9th
Range8.9–100.0%
Sessions1,210

Over the last 20 sessions SIGACHI settled 37.6% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 56.1%, so recent sessions are running 18.5 points lower than usual. The latest session ranks higher than 9% of the 1,210 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryPharmaceuticals
PeersDIVISLABLAURUSLABSSUNPHARMAWOCKPHARMADRREDDYMOREPENLAB

Performance returns

CSV
1D1W1M3M6M1Y
Price+4.07%+3.89%-8.17%+37.05%+54.63%-21.53%

Valuation

CSV
Market cap₹1,142 Cr
P/E (TTM)43.4
EPS (TTM)0.69
Shares outstanding38.21Cr
Listed15 Nov 2021

Ownership

CSV
Promoter36.69%
Promoter Δ QoQ0.00 pp
Public63.31%
FII1.25%
DII0.00%
Pledged20.04%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)110.5117.2121.9121.3
YoY chg——-4.9%-5.4%
Net profit (₹ Cr)10.5(0.0)7.68.1
YoY chg——-52.7%—
Net margin9.5%-0.0%6.3%6.7%
EPS0.280.010.200.18

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 36.69% · public 63.31%
13 Nov 2021: promoter 48.46%31 Dec 2021: promoter 48.48%31 Mar 2022: promoter 48.48%30 Jun 2022: promoter 48.48%30 Sept 2022: promoter 48.48%31 Dec 2022: promoter 48.49%31 Mar 2023: promoter 48.49%30 Jun 2023: promoter 48.49%30 Sept 2023: promoter 48.49%9 Oct 2023: promoter 46.08%31 Dec 2023: promoter 48.49%6 Mar 2024: promoter 45.43%31 Mar 2024: promoter 45.43%30 Jun 2024: promoter 45.43%30 Aug 2024: promoter 44.71%30 Sept 2024: promoter 44.71%31 Dec 2024: promoter 44.71%8 Feb 2025: promoter 44.14%31 Mar 2025: promoter 44.14%30 Jun 2025: promoter 44.14%30 Sept 2025: promoter 40.48%31 Dec 2025: promoter 39.70%31 Mar 2026: promoter 36.69%30 Jun 2026: promoter 36.69%
2021-112026-06
  • Promoter
  • Public and others
Promoter
36.69%
Public
63.31%
Promoter change
0.00 pp
Filed
18 Jul 2026
FII
1.25%
DII
0.00%
Promoter pledged
20.04%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25AQ4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations99.2110.9104.195.7124.9139.4128.2128.2110.5117.2121.9121.3
Other income1.11.77.21.714.62.02.23.92.50.51.31.0
Total income100.3112.7111.497.4139.5141.4130.4132.2113.0117.7123.2122.3
Total expenses82.193.094.281.0113.0114.7107.7112.2110.2118.8114.4112.2
└ Finance costs1.81.82.93.22.13.83.33.33.13.14.33.0
└ Depreciation2.52.83.53.13.24.74.74.74.14.24.64.4
Profit before tax18.219.617.216.426.526.722.7(101.0)7.4(1.9)7.710.1
Tax expense3.13.52.03.65.56.26.5(0.0)(3.1)(1.8)0.11.9
Net profit15.116.115.212.821.020.516.2(101.0)10.5(0.0)7.68.1
EPS0.490.510.480.400.660.650.36-2.630.280.010.200.18
Net margin15.24%14.52%14.57%13.33%16.83%14.71%12.61%-78.73%9.53%-0.01%6.27%6.72%
PBT margin18.37%17.70%16.53%17.13%21.25%19.16%17.68%-78.75%6.73%-1.58%6.33%8.32%
Tax rate17.01%18.00%11.86%22.17%20.83%23.19%28.67%—-41.64%—0.84%19.28%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 13 Aug 2026.

SIGACHI at a glance

  • SIGACHI closed at ₹29.89 on 6 Oct 2026, +4.07% on the day, -21.5% over one year, 26.8% below its 52-week high of ₹40.85.
  • Delivery was 27.3% of traded quantity on 6 Oct 2026, the 9th percentile of its own 1,210 sessions with a reading (20-session average 37.6%, 1-year average 56.1%).
  • Market capitalisation is ₹1,142 crore at a trailing P/E of 43.4 (trailing EPS ₹0.69).
  • Q1 FY27 results (consolidated, filed 13 Aug 2026): revenue ₹121 crore (-5.4% year on year), net profit ₹8 crore; the price moved -1.8% on the first session after.
  • Promoters held 36.69% at 30 Jun 2026, unchanged on the previous filing, with 20.04% of promoter shares pledged.
  • Q2 FY27 results are expected between 24 Oct 2026 and 14 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE0D0K01022
SeriesEQ
Listed15 Nov 2021
History from15 Nov 2021
Sessions1,213
Turnover rank#790

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Pharmaceuticals & Biotechnology

CSV

All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE